User profiles for Francesco Scolari

Francesco Scolari

cattedra di nefrologia università di brescia
Verified email at unibs.it
Cited by 22569

Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in …

…, G Romanelli, M Rossi, M Salvetti, F Scolari… - Autoimmunity …, 2020 - Elsevier
… Author links open overlay panel Paola Toniati a 1 , Simone Piva b c 1 , Marco Cattalini d
e 1 , Emirena Garrafa f g 1 , Francesca Regola a e , Francesco Castelli e h , Franco …

Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria

…, G Gherardi, G Garini, C Zoccali, M Salvadori, F Scolari… - The Lancet, 1999 - thelancet.com
Background Stratum 2 of the Ramipril Efficacy in Nephropathy (REIN) study has already
shown that in patients with chronic nephropathies and proteinuria of 3 g or more per 24 h, …

The pathophysiology of IgA nephropathy

…, AB Herr, MB Renfrow, RJ Wyatt, F Scolari… - Journal of the …, 2011 - journals.lww.com
Here we discuss recent advances in understanding the biochemical, immunologic, and genetic
pathogenesis of IgA nephropathy, the most common primary glomerulonephritis. Current …

A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy.

C Ponticelli, P Altieri, F Scolari… - Journal of the …, 1998 - journals.lww.com
To assess whether chlorambucil or cyclophosphamide may have a better therapeutic index
in patients with idiopathic membranous nephropathy, we compared two regimens based on …

Genome-wide association study identifies susceptibility loci for IgA nephropathy

…, F Bertinetto, P Mesiano, A Amoroso, F Scolari… - Nature …, 2011 - nature.com
We carried out a genome-wide association study of IgA nephropathy, a major cause of kidney
failure worldwide. We studied 1,194 cases and 902 controls of Chinese Han ancestry, with …

[HTML][HTML] A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia

…, S Affatato, M Gaggiotti, N Bossini, F Scolari - Kidney international, 2020 - Elsevier
The outcome of SARS-CoV2 infection in patients who have received a kidney allograft and
are being treated with immunosuppression is unclear. We describe 20 kidney transplant …

Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens

K Kiryluk, Y Li, F Scolari, S Sanna-Cherchi, M Choi… - Nature …, 2014 - nature.com
We performed a genome-wide association study (GWAS) of IgA nephropathy (IgAN), the most
common form of glomerulonephritis, with discovery and follow-up in 20,612 individuals of …

[HTML][HTML] Management of patients on dialysis and with kidney transplantation during the SARS-CoV-2 (COVID-19) pandemic in Brescia, Italy

…, N Bossini, M Gaggiotti, F Scolari… - Kidney International …, 2020 - Elsevier
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as coronavirus
disease (COVID-19), is a major pandemic challenging health care systems around the …

[HTML][HTML] Renal outcome in patients with congenital anomalies of the kidney and urinary tract

…, D Somenzi, A Trivelli, G Caridi, C Izzi, F Scolari… - Kidney international, 2009 - Elsevier
Congenital Anomalies of the Kidney and Urinary Tract (CAKUT) are a major cause of
morbidity in children. We measured the risk of progression to end-stage renal disease in 312 …

IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22–23

AG Gharavi, Y Yan, F Scolari, FP Schena, GM Frasca… - Nature …, 2000 - nature.com
End-stage renal disease (ESRD) is a major public health problem, affecting 1 in 1,000 individuals
and with an annual death rate of 20% despite dialysis treatment 1, 2. IgA nephropathy (…